Biomarker Strategies for Optimizing Checkpoint Immunotherapy Treatment

Explore an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers

Unlock Webinar
[wpbb post:title]
Dr. Naval Daver, Associate Professor, Department of Leukemia, MD Anderson Cancer Center

  • Review advanced immune-based approaches in acute myeloid leukemia that combine chemotherapy with checkpoint therapy

  • Explore relevant biomarker strategies associated with these approaches

  • See how single-cell cytokine analysis system and PSI demonstrate that specific cytokine potency contributors correlate with overall survival

fierce innovation awards
red dot award
the scientist top 10 innovation award
2021-06-03T16:40:56-04:00